The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells

Current Eye Research

Volumn 17, Issue 9, 1998, Pages 924-932

  McDermott, Alison M ^a   Kern, Timothy S ^b   Murphy, Christopher J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adhesion; Corneal epithelium; Diabetes; Human; Migration; Proliferation

Indexed keywords

CALCEIN; COLLAGEN TYPE 1; FIBRONECTIN; GLUCOSE; MANNITOL;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CORNEA EPITHELIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIMIAN VIRUS 40;

CELL ADHESION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; CORNEA; EPITHELIAL CELLS; FIBRONECTINS; FLUORESCEINS; FLUORESCENT DYES; GLUCOSE; HUMANS; SIMIAN VIRUS 40;

EID: 0031654517     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.9.924.5133     Document Type: Article

References (62)

1. Willis RM. Endocrine diseases and the cornea. In: Krachmer JH, Mannis MJ, Holland EJ. Cornea Diagnosis and Management, St. Louis, MO: Mosby; 1997:979-988.
2. Parrish CM. The cornea in diabetes mellitus. In: Feman SS. Ocular Problems in Diabetes Mellitus, Boston, MA: Blackwell Scientific Publications, 1992:179-205.
3. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optometry Physiological Optics. 1988;65:224-230.
4. Fukushi S, Merola LO, Tanaka M, Datiles M, Kinoshita JH. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res. 1980;31:611-621.
5. Crouch ER III, Breazeale RI, Crouch ER Jr, Davidson JC, Lattanzio FA, Williams PB. Corneal wound healing in a diabetic rabbit model. Invest Ophthalmol Vis Sci. 1997; 38:8403.
6. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983;24:563-569.
7. Foulks GN, Thoft RA, Pery HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol. 1979;97:1076-1078.
8. Friend J, Kiorpes TC, Thoft RA. Diabetes mellitus and the rabbit corneal epithelium. Invest Ophthalmol Vis Sci. 1981; 21:317-321.
9. Marano CW, Matschinsky FM. Biochemical manifestations of diabetes mellitus in microscopic layers of the cornea and retina. Diabetes/Metabolism Reviews. 1989;5:1-15.
10. Friend J, Ishii Y, Thoft RA. Corneal epithelial changes in diabetic rats. Ophthalmic Res. 1982;14:269-278.
11. Gasset AR, Braverman LE, Fleming MC, Arky RA, Alter BR. Tear glucose detection of hyperglycaemia. Am J Ophthalmol. 1968;65:414-420.
12. Motoji K. The glucose content of tear fluid in normal and diabetic subjects. Jpn J Clin Ophthalmol. 1971;25:1945-1950.
13. Sen DK, Sarin GS. Tear glucose levels in normal people and in diabetic patients. Br J Ophthalmol. 1980;64:693-695.
14. Barcaroli M, Del Beato P, Tanzilli P, De Mattia G, Vingolo EM. Diabetes mellitus and dry eye syndrome: tear film glucose level in diabetic patients. Invest Ophthalmol Vis Sci. 1997;38:S150.
15. Hayashi JN, Ito H, Kanayasu T, et al. Effects of glucose on migration, proliferation and tube formation by vascular endothelial cells. Virchows Archiv. 1991;60:245-252.
16. Mascardo RN. The effects of hyperglycaemia on the directed migration of wounded endothelial cell monolayers. Metab Clin Exp. 1988;37:378-385.
17. Suzuki N, Svensson K, Eriksson UJ. High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia. 1996;39:401-411.
18. Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA. 1993;90:9640-9644.
19. Setty S, Anderson SS, Wayner EA, Kim Y, Clegg DO, Tsilibary EC. Glucose-induced alteration of integrin expression and function in cultured human mesangial cells. Cell Adhesion Commun. 1995;3:187-200.
20. Porta M, La Selva M, Bertagna A, Molinatti GM. High glucose concentrations inhibit DNA synthesis and replication without causing death or impairing injury repair in cultured human endothelial cells. Diabetes Research. 1988;7:59-63.
21. Okuda Y, Nagahama M, Mizutani M, Bannai C, Yamashita K. Ascorbic acid prevents the inhibition of DNA synthesis induced by high glucose concentration in culture human endothelial cells. Diabetes Research. 1991;18:65-68.
22. Curcio F, Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by anti-oxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol. 1992;28A:787-790.
23. La Selva M, Molinatti PA, Porta M, Molinatti GM. Aspirin and salicylate do not modify impaired endothelial cell replication at high glucose concentrations. Diabetes Research. 1988;8:49-50.
24. Ceriello A, dello Russo P, Amstad P, Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycaemia and oxidative stress. Diabetes. 1996;45:471-477.
25. La Selva M, Beltramo E, Pagnozzi F, et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia. 1996;39:1263-1268.
26. Nahman NS, Leonhart KL, Cosio FG, Herbert CL. Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int. 1992;41:396-402.
27. Yao J, Li S. Role of transforming growth-factor-β in the growth inhibition of cultured rat mesangial cells in high glucose. Chinese Med J. 1994;107:455-459.
28. Trachtman H, Futterweit S, Prenner J, Hanon S. Antioxidants reverse the antiproliferative effects of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Communs. 1994; 199:346-352.
29. Pugliese G, Pricci F, Locuratolo N, Romeo G, Giannini S, Cresci B, Galli G, Rotella CM, Di Mario U. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions: relation to glucose-enhanced extracellular matrix production. Diabetologia. 1996;39:775-784.
30. Matsuo H, Yamasaki H, Matsumoto K, et al. Adenosine 3′5′-cyclic monophosphate mimics the inhibitory effect of high glucose on MAP kinase phosphorylation in rat mesangial cells. Biochem Biophys Res Communs. 1996;226:746-754.
31. Cosio FG. Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol. 1995;5: 1600-1609.
32. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension. 1996;28:159-168.
33. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of culture rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol. 1995;15:2207-2212.
34. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Communs. 1992;187:552-560.
35. Liu YJ, Saini A, Cohen DJ, Ooi BS. Modulation of macrophage proliferation by hyperglycaemia. Mol Cell Endocrinol. 1995;114:187-192.
36. El-Khatib M, Radin NS, Shayman JA. Glycosphingolipid synthesis and proliferation in a renal cell line grown in high glucose. Am J Physiol. 1996;270:F476-F484.
37. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes. 1991;40:102-110.
38. Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells: differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem. 1991;266:14244-14250.
39. Moritani S. Glucose-induced production of type IV collagen and laminin p1 from cultured human umbilical vein endothelial cells. J Diabetic Complications. 1991;5:201-203.
40. Bakillah A, Grigorova-Borsos AM, Guillot R, Urios P, Sternberg M. Effect of an aldose reductase inhibitor on type IV collgen production by human endothelial cells cultured in high glucose. Diabetologia. 1996;39:641-648.
41. Grigorova-Borsos AM, Bakillah A, Urios P, Leblond V, Guillot R, Sternberg M. Production of type IV collagen and 72-kDa gelatinase by human endothelial cells cultured in high glucose: effects of a protein kinase C inhibitor, GF 109203X. Biochem Cell Biol. 1996;74:659-667.
42. Ayo SH, Radnik RA, Garoni JA, Glass WF, Kreisberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol. 1990; 136:1339-1348.
43. Pugliese G, Pricci F, Pugliese F, et al. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 1994;43:478-490.
44. Ziyadeh FN, Fumo P, Rodenberger CH, Kuncio GS, Neilson EG. Role of protein kinase C and cyclic AMP/protein kinase A in high glucose-stimulated transcriptional activation of collagen alpha 1 (IV) in glomerular mesangial cells. J Diabetes Complications. 1995;9:255-261.
45. Wenzel S, Stolte H, Soose M. Effects of silibinin and anti-oxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cells. J Pharm Exp Thera. 1996;279:1520-1526.
46. van Det NF, Verhagen NAM, Tamsma JT, et al. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes. 1997;46:834-840.
47. van Det NF, van den Born J, Tamsma JT, et al. Effects of high glucose on the production of heparan sulphate proteoglycan by mesangial and epithelial cells. Kidney Int. 1996;49:1079-1089.
48. Kasinath BS. Effect of insulin on high-glucose medium-induced changes in rat glomerular epithelial cell metabolism of glycoconjugates. Arch Biochem Biophys. 1995; 318:286-294.
49. Kasinath BS, Grellier P, Choudhury GG, Abboud SL. Regulation of basement membrane heparan sulphate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium. J Cell Physiol. 1996;167:131-136.
50. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
51. McDermott AM, Kern TS, Murphy CJ. Effect of elevated extracellular glucose on adhesion and migration of SV40 transformed human corneal epithelial cells. Invest Ophthalmol Vis Sci. 1997;38:S403.
52. Lee CH, Nelson M, Murphy CJ. Migration and proliferation characteristics of SV40 transformed human corneal epithelial cells in response to neuropeptides. Invest Ophthalmol Vis Sci. 1996;37:S861.
53. Gould GW, Seatter MJ. Introduction to the facultative glucose transporter family. In: Gould GW. Facilitative Glucose Transporters, Austin, TX: R.G. Landes Company; 1997:1-37.
54. Kumagai AK, Glasgow BJ, Pardridge WM. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci. 1994;35:2887-2894.
55. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J. 1994;8: 43-53.
56. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle and accelerated death. Diabetes. 1985;34:621-627.
57. Studer RK, Craven PA, DeRubertis FR. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metab Clin Exp. 1997;46:918-925.
58. Tada H, Ishii H, Isogai S. Protective effect of D-α-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metab Clin Exp. 1997;46: 779-784.
59. Brownlee M. Glycation and diabetic complications. Diabetes. 1994;43:836-841.
60. Schmidt AM, Hori O, Cao R, et al. RAGE: a novel cellular receptor for advanced glycation end-products. Diabetes. 1996;45:S77-80.
61. Abdel-Wahab YHA, O'Harte FPM, Barnett CR, Flatt PR. Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture. J Endocrinol. 1997;152: 59-67.
62. Giardino I, Edelstein D, Brownlee M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J Clin Invest. 1994;94: 110-117.